Posters

Evaluation of a new capsulotomy fixated aspheric IOL after femtosecond laser-assisted cataract surgery (FLACS)

Poster Details

First Author: A. Osinga GERMANY

Co Author(s):    D. Breyer   H. Kaymak   K. Klabe   P. Hagen   F. Kretz   G. Auffarth     

Abstract Details

Purpose:

The high precision, predictability and reproducibility of a FLACS capsulotomy can be used for a new generation of capsulotomy fixated IOLs to eventually improve the visual outcome of lens surgery. The aim of this study was the evaluation of the visual and refractive outcomes as well as centration and tilt of a new capsulotomy fixated IOL (Oculentis) after FLACS.

Setting:

All FLACS (LensAR, Topcon) and follow-ups were performed at the Breyer-Kaymak-Klabe Eyesurgery in Duesseldorf, Germany, which is part of the International Vision Correcton Research Center (IVCRC.net).

Methods:

This prospective study comprises results after bilateral implantation of a new capsulotomy fixated IOL. Each eye was documented postoperatively 1-7 days, 4-6 weeks and 6 months. Manifest refraction, visual acuity, IOL position (photography at slitlamp) and IOL tilt (measured with the Scheimpflug Tomography) were evaluated.

Results:

So far, 10 patients are actively enrolled in the study. Mean monocular UDVA was 0.12logMAR and monocular CDVA was 0.00logMAR. IOL-rotation was below 5°, where we estimated the precision of the IOL-rotation measurement to be approximately 2-3°.

Conclusions:

The first results show a very well centering of the capsulotomy fixated IOL with almost no tilt and rotation over the first months. After adaption of the IOL calculation formula, an improvement in IOL calculation and residual refraction is to be expected.

Financial Disclosure:

One or more of the authors receives consulting fees, retainer, or contract payments from a company producing, developing or supplying the product or procedure presented, One or more of the authors travel has been funded, fully or partially, by a competing company, One or more of the authors travel has been funded, fully or partially, by a company producing, developing or supplying the product or procedure presented, One or more of the authors receives consulting fees, retainer, or contract payments from a competing company